AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.93
+1.29%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 9.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -8.72x
- Price / sales
- 9.12x
- Price / cash flow
- -10.87x
Enterprise value
- Enterprise value
- $453.8M
- EV / sales
- 8.39x
- EV / EBITDA
- -7.39x
- EV / EBIT
- -8.60x
- Market cap
- $493.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026